Indefinite Delivery Contract SPE2DB20D9129

The Defense Logistics Agency (DLA), a logistics combat support agency within the Department of Defense, awarded a single-award indefinite delivery contract (IDC) valued up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities worldwide.

Under this IDC, DMS Pharmaceutical Group has received multiple delivery orders to supply a variety of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. Examples of products delivered include Botox, Mirena and Nexplanon contraceptive devices, Exparel pain medication, and common medications like antibiotics and cardiovascular drugs. These delivery orders, which have no set-aside designations, enable DMS Pharmaceutical Group to serve as a prime vendor for the DLA and Department of Defense, providing both routine and specialized pharmaceuticals to military treatment facilities globally.